Home | Welcome to Contract Pharma   
Last Updated Wednesday, June 3 2015

Print

Search Results for 'AMRI'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Contract Service Directory Companies

View All Companies »


Search Results:

Published May 5, 2015
Contract revenue up 47% in the quarter Read More »
Published April 6, 2015
Activities will be transitioned to other facilities, affecting approx. 62 positions Read More »
Consolidation in Outsourcing
By Michael A. Martorelli , Director, Fairmount Partners
Published March 6, 2015
Reviewing 2014’s M&A activity Read More »
Published February 12, 2015
Contract revenue up 35% in the quarter Read More »
Published February 10, 2015
Wang brings 25 years of IT experience Read More »
Published January 19, 2015
Will support development and manufacture of drug candidates for neurological disorders Read More »
Published January 12, 2015
Ladin to replace Nolan Read More »
Published January 12, 2015
AMRI to provide cGMP manufacture and analytical support for five candidates Read More »
Published January 9, 2015
Expands AMRI's drug product development and aseptic clinical manufacturing capabilities Read More »
Published November 19, 2014
Completes remediation following an environmental deviation Read More »
Published November 7, 2014
Contract revenue up 8% in the quarter Read More »
Published August 5, 2014
Cedarburg business boosts large scale manufacturing revenue Read More »
Published June 2, 2014
Expands commercial manufacturing capabilities for specialty injectables Read More »
Published May 6, 2014
Decline in royalties impacts results Read More »
Published April 16, 2014
Will transition DDS ops to other sites Read More »
Published April 7, 2014
Expands resources for complex drug development services and products Read More »
Published April 3, 2014
AMRI has signed a definitive agreement to acquire all outstanding shares of Cedarburg Pharmaceuticals, Inc., a contract developer and manufacturer of complex API’s, for $38.2 million in cash. The transaction expands AMRI’s position as a s… Read More »
By Kristin Brooks
Published March 24, 2014
Expands custom API products and services Read More »
By Kristin Brooks
Published February 12, 2014
Achieves record contract revenues Read More »
By Kristin Brooks
Published January 10, 2014
Svokos, Batra bring experience from Teva Read More »
Published November 6, 2013
Contract revenue up 16% in the quarter Read More »
Published November 5, 2013
Resolves all issues at Burlington facility Read More »
Published October 16, 2013
Luther brings extensive discovery experience Read More »
Published September 30, 2013
Will supply product for Phase I trials Read More »
Published September 9, 2013
Marth to succeed D'Ambra Read More »
Published August 6, 2013
Revenues up 19% in the quarter Read More »
Published July 23, 2013
Issues Form 483 for three inspectional observations Read More »
Published June 18, 2013
Registered to handle Schedule 2 and 2N controlled substances Read More »
Published June 17, 2013
Collins to lead North American discovery business development activities Read More »
Published June 6, 2013
Teva veteran Marth to serve in role held by D'Ambra Read More »
Published May 7, 2013
Revenues up 11% in the quarter Read More »
Published April 24, 2013
SMARTSOURCING pact may range from discovery to cGMP Read More »
Published February 25, 2013
Yura to head discovery and development services Read More »
Published February 13, 2013
Aims to improve manufacturing routes for selected APIs Read More »
Published February 12, 2013
Unaudited revenues up 44% in the quarter Read More »
By Gil Roth
Published February 11, 2013
Chai to take over tubulin compound Read More »
Published January 8, 2013
Saffee to oversee India, NY and UK operations Read More »
Published December 6, 2012
Will supply ABA product from Rensselaer facility Read More »
Published November 30, 2012
To close Bothell, WA site Read More »
Published November 6, 2012
Large-scale manufacturing revenue up 14% Read More »
By Gil Roth
Published October 22, 2012
Hagen moves up to SVP Read More »
Published October 19, 2012
Five-year supply agreement covers undisclosed product Read More »
Published September 17, 2012
Combines drug discovery capabilities with CNS experience Read More »
Published September 12, 2012
Nolan succeeds Frost Read More »
Published September 10, 2012
Conlon to lead North America sales team Read More »
Published August 1, 2012
Contract revenue down 3% in the quarter Read More »
By Gil Roth
Published June 20, 2012
Hires two, relocates custom library synthesis resources Read More »
By Gil Roth
Published June 5, 2012
Burlington site to handle sterile pre-filled syringes Read More »
Published May 22, 2012
Shott to lead business operations in Europe Read More »
By Gil Roth
Published May 9, 2012
Hungary closure leads to charges Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On